.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Argus Health
Fuji
Cerilliant
Farmers Insurance
Dow
Deloitte
UBS
Teva
Express Scripts

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072710

« Back to Dashboard
NDA 072710 describes SULINDAC, which is a drug marketed by Epic Pharma, Sandoz, Mylan, Sun Pharm Inds, Heritage Pharms Inc, Ani Pharms Inc, and Watson Labs, and is included in twelve NDAs. It is available from twenty-one suppliers. Additional details are available on the SULINDAC profile page.

The generic ingredient in SULINDAC is sulindac. There are fourteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sulindac profile page.

Summary for NDA: 072710

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 072710

Suppliers and Packaging for NDA: 072710

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULINDAC
sulindac
TABLET;ORAL 072710 ANDA PuraCap Laboratories, LLC 24658-770 24658-770-01 100 TABLET in 1 BOTTLE (24658-770-01)
SULINDAC
sulindac
TABLET;ORAL 072710 ANDA PuraCap Laboratories, LLC 24658-770 24658-770-05 500 TABLET in 1 BOTTLE (24658-770-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG
Approval Date:Mar 25, 1991TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
QuintilesIMS
Deloitte
Cerilliant
Cantor Fitzgerald
Healthtrust
Julphar
McKinsey
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot